Clinical Trials Directory

Trials / Unknown

UnknownNCT02691897

Melatonin's Effects on Treatment Of Diabetes Mellitus

The Effects of Melatonin on Serum Glucose Levels of Patients With Type 2 Diabetes Mellitus

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess the efficacy and safety of melatonin in control of blood sugar in patients with type 2 diabetes mellitus (DM).

Detailed description

Diabetes mellitus (DM) is a major public health problem with increasing worldwide incidence. The main causes for increase in incidence of DM are inactivity, obesity and changes of dietary habits. Investigators think that the changes in the awake-sleep cycle may also contribute to higher incidence of DM in recent years. Melatonin is an important component of the circadian system. Numerous experimental studies have demonstrated that melatonin has many beneficial actions.Melatonin is a potent antioxidant, reduces inflammatory process, lowers blood pressure, improve lipid profiles. Collectively, these data suggest that melatonin may be useful in control of blood sugar in patients with DM. The aim of this study is to assess the efficacy of melatonin in control of blood sugar in patients with type 2 DM.

Conditions

Interventions

TypeNameDescription
DRUGMelatoninMelatonin 3mg once daily at bedtime
DRUGPlaceboPlacebo 1 tablet once daily at bedtime

Timeline

Start date
2019-07-01
Primary completion
2020-05-01
Completion
2020-07-01
First posted
2016-02-25
Last updated
2019-04-08

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02691897. Inclusion in this directory is not an endorsement.